Trial Profile
DWP450 Versus Botox in Treatment of Post Stroke Upper Limb Spasticity
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Registrational; Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 01 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2013 New trial record